SMH 1st in Region to Earn TAVR Certification from ACC

SMH 1st in Region to Earn TAVR Certification from ACC

The American College of Cardiology (ACC) has recognized Sarasota Memorial and its Structural Heart Team for expertise in TAVR (transcatheter valve replacement procedures ). According to the ACC, Sarasota Memorial is the first hospital in Southwest Florida to be awarded Transcatheter Valve Certification.

Thursday, December 17, 2020/Author: Anonym/Number of views (1835)/Comments (0)/
Tags:
SMH Continues Straight-A Streak in Fall 2020 Hospital Safety Report Card

SMH Continues Straight-A Streak in Fall 2020 Hospital Safety Report Card

Sarasota Memorial Hospital again earned an A for patient safety in The Leapfrog Group's Fall 2020 hospital report cards report.

Monday, December 14, 2020/Author: Anonym/Number of views (1691)/Comments (0)/
Tags:
SMH Welcomes 2 New Family Medicine Specialists to Physicians Network

SMH Welcomes 2 New Family Medicine Specialists to Physicians Network

Sarasota Memorial Health Care System is welcoming 2 new family practice physicians to its First Physicians Group (FPG) network and the Suncoast community this month: Jessica Perez-Cardwell, MD, and Rebecca Workman, DO.

Wednesday, December 9, 2020/Author: Anonym/Number of views (2126)/Comments (0)/
Tags:
5 S’s to Lower Your Holiday Stresses

5 S’s to Lower Your Holiday Stresses

By SMH Behavioral Health Services Manager Jill Hazzard, LMHC

The holidays can be magical, but they can also be stressful. The 2020 holiday season, of course, has the added stressors of COVID-19. Give yourself the gift of less stress this year with these easy steps.

Tuesday, December 8, 2020/Author: Anonym/Number of views (1536)/Comments (0)/
Tags:
Monoclonal Antibody Therapy for High Risk COVID-19 Outpatients

Monoclonal Antibody Therapy for High Risk COVID-19 Outpatients

Sarasota Memorial is among a number of hospitals that have been allocated a limited supply of monoclonal antibody therapy for non-hospitalized patients who have been diagnosed with a mild-to-moderate case of COVID-19 and have a high risk for severe disease or hospitalization. SMH has received a limited supply of the Eli Lilly drug (bamlanivimab) and expects to receive shipments of Regeneron’s experimental antibody treatment (a combination of casirivimab and imdevimab), in the coming weeks/months, as supplies are available.

Thursday, December 3, 2020/Author: Anonym/Number of views (5778)/Comments (0)/
Tags:
RSS
First2021222325272829Last